Valicenti Advisory Services’s VanEck Pharmaceutical ETF PPH Stock Holding History

Valicenti Advisory Services’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-34,995	Closed	-$3.33M	–	73
2024 Q3	$3.33M	Sell	34,995 -65	-0.2%	-$6.17K	0.85%	32
2024 Q2	$3.21M	Buy	35,060 +17,655	+101%	+$1.58M	0.86%	29
2024 Q1	$1.58M	Sell	17,405 -56,686	-77%	-$4.96M	0.44%	48
2023 Q4	$6.03M	Sell	74,091 -5,423	-7%	-$425K	1.83%	17
2023 Q3	$6.35M	Buy	79,514 +3,319	+4%	+$268K	2.17%	15
2023 Q2	$6M	Sell	76,195 -5,020	-6%	-$393K	1.9%	17
2023 Q1	$6.3M	Buy	81,215 +9,285	+13%	+$716K	2.1%	16
2022 Q4	$5.59M	Buy	+71,930	New	+$5.31M	2.04%	16

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

MTWSIF

Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Valicenti Advisory Services's PPH Position: Q4 2024 in Review

Valicenti Advisory Services sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2024, closing a stake of 34,995 shares — an estimated $3.33M sold.

Valicenti Advisory Services first reported a position in PPH in Q4 2022 and held it in 8 quarters. The position peaked at $6.35M in Q3 2023. 142 funds tracked by Wall St. Rank hold PPH as of Q4 2024.

Valicenti Advisory Services reported no remaining VanEck Pharmaceutical ETF position as of Q4 2024 after selling out during the quarter.
Valicenti Advisory Services sold 34,995 VanEck Pharmaceutical ETF shares in Q4 2024, an estimated $3.33M.
Valicenti Advisory Services first reported a position in VanEck Pharmaceutical ETF in Q4 2022 and held it in 8 quarters.
Valicenti Advisory Services's VanEck Pharmaceutical ETF position peaked at $6.35M in Q3 2023.
142 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2024.

Based on Valicenti Advisory Services's 13F filing for Q4 2024, filed 23 Jan 2025.